Cargando…
Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report
We describe a case of an otherwise healthy 60‐year‐old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID‐19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969541/ https://www.ncbi.nlm.nih.gov/pubmed/36860723 http://dx.doi.org/10.1002/ccr3.6012 |
| _version_ | 1784897756442132480 |
|---|---|
| author | Gonzalez, Susan Levine, David M. |
| author_facet | Gonzalez, Susan Levine, David M. |
| author_sort | Gonzalez, Susan |
| collection | PubMed |
| description | We describe a case of an otherwise healthy 60‐year‐old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID‐19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis. |
| format | Online Article Text |
| id | pubmed-9969541 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99695412023-02-28 Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report Gonzalez, Susan Levine, David M. Clin Case Rep Case Report We describe a case of an otherwise healthy 60‐year‐old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID‐19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis. John Wiley and Sons Inc. 2023-02-27 /pmc/articles/PMC9969541/ /pubmed/36860723 http://dx.doi.org/10.1002/ccr3.6012 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Case Report Gonzalez, Susan Levine, David M. Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report |
| title | Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report |
| title_full | Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report |
| title_fullStr | Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report |
| title_full_unstemmed | Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report |
| title_short | Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report |
| title_sort | upper extremity deep venous thrombosis after bnt162b2 mrna covid‐19 vaccine case report |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969541/ https://www.ncbi.nlm.nih.gov/pubmed/36860723 http://dx.doi.org/10.1002/ccr3.6012 |
| work_keys_str_mv | AT gonzalezsusan upperextremitydeepvenousthrombosisafterbnt162b2mrnacovid19vaccinecasereport AT levinedavidm upperextremitydeepvenousthrombosisafterbnt162b2mrnacovid19vaccinecasereport |